Ambu surpasses Q1 expectations and hits significant milestone

Medtech firm Ambu surpasses analyst expectations for Q1 with revenue exceeding DKK 1bn. For the first time, the firm hits the billion-kroner mark already in Q1.

Photo: PR / Ambu

Ambu is powering ahead in its Q1. For the first time, the pharmaceutical firm's revenue has reached the DKK 1bn (USD 163.3m) mark early in the year.

All in all, Ambu has had a revenue of DKK 1,013m in the first three months of the company's staggered fiscal year. This greatly surpasses the DKK 760m which the firm scraped together in the same time period in the last financial year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs